Valuation: Baxter International Inc.

Market Cap 13.34B 11.97B 10.94B 9.98B 18.81B 1,254B 19.4B 132B 52.57B 669B 50.08B 49.01B 2,113B P/E 2026 *
20.8x
P/E 2027 * 18.8x
Enterprise Value 20.17B 18.09B 16.54B 15.09B 28.44B 1,896B 29.33B 199B 79.47B 1,012B 75.72B 74.09B 3,194B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.63x
Free-Float
75.44%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day+0.55%
1 week+12.13%
Current month+12.13%
1 month+5.87%
3 months-4.52%
6 months+51.88%
Current year+34.96%
1 week 23.26
Extreme 23.265
27.08
1 month 22.5
Extreme 22.495
27.08
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 01/08/2025
Chief Tech/Sci/R&D Officer 57 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 18/02/2019
Director/Board Member 65 01/01/2019
Director/Board Member 69 15/02/2021
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Other

EVP and CFO

0 0% -
02/09/26 Tax

President, Front Line Care

-2,098 0.0004%
02/09/26 Tax

Chief Executive Officer

-54,276 0.0105%
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%+12.13%+43.44%-25.22% 13.34B
-3.23%+3.51%-12.02%+15.72% 190B
-2.90%+5.45%+13.04%+38.65% 125B
-2.75%+11.65%-7.90%+17.71% 124B
+0.96%+5.15%-38.02%+12.24% 99.31B
-1.80%+0.82%-7.41%+69.42% 63.65B
-0.78%+7.07%+19.44%-18.22% 57.71B
+0.79%+22.65%-5.28%+59.81% 53.26B
-6.98%-14.56%-12.60%+42.69% 47.03B
-2.36%+3.72%+3.27%-8.07% 36.15B
Average -1.85%+5.95%-0.41%+20.47% 80.95B
Weighted average by Cap. -2.16%+5.81%-6.11%+23.66%

Financials

2026 *2027 *
Net sales 11.72B 10.52B 9.61B 8.77B 16.53B 1,102B 17.05B 116B 46.19B 588B 44.01B 43.06B 1,856B 11.96B 10.73B 9.8B 8.95B 16.86B 1,124B 17.39B 118B 47.12B 600B 44.89B 43.93B 1,894B
Net income 621M 557M 509M 465M 875M 58.37B 903M 6.13B 2.45B 31.14B 2.33B 2.28B 98.32B 601M 539M 493M 450M 848M 56.53B 874M 5.94B 2.37B 30.16B 2.26B 2.21B 95.22B
Net Debt 6.83B 6.13B 5.6B 5.11B 9.63B 642B 9.93B 67.48B 26.91B 343B 25.64B 25.09B 1,081B 6.14B 5.51B 5.04B 4.6B 8.66B 578B 8.93B 60.7B 24.21B 308B 23.06B 22.57B 973B
Projected Income Statement - Annual - Baxter International Inc.
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
06/11/26 $25.79 +0.55% 6,195,174
05/11/26 $25.65 -3.21% 10,103,099
04/11/26 $26.50 +3.96% 10,491,636
03/11/26 $25.49 +5.24% 9,397,478
02/11/26 $24.22 +5.30% 10,163,351
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Baxter International Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
25.79USD
Average target price
27.25USD
Spread / Average Target
+5.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Baxter International Inc.